COPD, or chronic obstructive pulmonary disease, affects more than 30 million Americans, yet many have never heard of it. COPD ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Mandal, Ananya. (2023, July 03). Chronic Obstructive Pulmonary Disease Process.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2023 Report. Global Initiative for Chronic Obstructive Lung Disease. 2022.

Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.

How gum disease aggravates chronic obstructive pulmonary disease. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 01 / 240114212121.htm ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL. The FDA has approved GSK’s Nucala ...

FDA Approves Nucala for Chronic Obstructive Pulmonary Disease. More. HealthDay. By Stephanie Brown HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) ...

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD diagnosis — work to save lives by providing access to pulmonary rehab ...